624
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

High attrition among HIV-infected patients with advanced disease treated in an intermediary referral center in Maputo, Mozambique

, , , , , , , , & show all
Article: 23758 | Received 06 Jan 2014, Accepted 08 Mar 2014, Published online: 08 Apr 2014

References

  • UNAIDS. UNAIDS report on the global AIDS epidemic. 2013. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf [cited 15 December 2013]..
  • Mortalidade em Moçambique. Inquérito Nacional sobre Causas de Mortalidade, 2007/8 – Relatório Preliminar. 2009. Available from: http://196.28.235.11/inqueritos_dir/INCAM/incam.pdf [cited 15 December 2013]..
  • Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007; 4: e298.
  • WHO, UNAIDS, UNICEF. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector, treatment and care for people living with HIV. 2010. Available from: http://www.unicef.org/eapro/Towards_Universal_Access_on_HIVAIDS.pdf [cited 15 December 2013]..
  • Lamb MR, Fayorsey R, Nuwagaba-Birbonwoha H, Viola V, Mutabazi V, Alwar T, etal. High attrition before and after ART initiation among youth (15–24 years of age) enrolled in HIV care. AIDS. 2014; 28: 559–68.
  • Lambdin BH, Micek MA, Sherr K, Gimbel S, Karagianis M, Lara J, etal. Integration of HIV care and treatment in primary health care centers and patient retention in central Mozambique: a retrospective cohort study. J Acquir Immune Defic Syndr. 2013; 62: e146–52.
  • Lambdin BH, Micek MA, Koepsell TD, Hughes JP, Sherr K, Pfeiffer J, etal. Patient volume, human resource levels, and attrition from HIV treatment programs in central Mozambique. J Acquir Immune Defic Syndr. 2011; 57: e33–9.
  • Médecins Sans Frontières, Operational Center Geneva Mozambique. Annual report of medical activities. 2011. Maputo, Mozambique.
  • Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, etal. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011; 365: 493–505.
  • Ministry of Health Mozambique. Guia de Tratamento Antiretroviral e Infecç[otilde]es Oportunistas no Adulto, Adolescente e Grávida 2009/2010. Maputo, Mozambique.
  • Auld AF, Mbofana F, Shiraishi RW, Sanchez M, Alfredo C, Nelson LJ, etal. Four-year treatment outcomes of adult patients enrolled in Mozambique's rapidly expanding antiretroviral therapy program. PLoS One. 2011; 6: e18453.
  • UNAIDS World AIDS Day report. 2012. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/jc2434_worldaidsday_results_en.pdf 2012 [cited 15 December 2013]..
  • Van Cutsem G, Ford N, Hildebrand K, Goemaere E, Mathee S, Abrahams M, etal. Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis. PLoS One. 2011; 6: e14684.
  • Brinkhof MWG, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One. 2009; 4: e5790.
  • Tweya H, Feldacker C, Estill J, Jahn A, Ng'ambi W, Ben-Smith A, etal. Are they really lost? “True” status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in urban Malawi. PLoS One. 2013; 8: e75761.
  • Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, Regensberg L, etal. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr. 2006; 43: 78–84.
  • Adjorlolo-Johnson G, Wahl Uheling A, Ramachandran S, Strasser S, Kouakou J, Tindyebwa D, etal. Scaling up pediatric HIV care and treatment in Africa: clinical site characteristics associated with favorable service utilization. J Acquir Immune Defic Syndr. 2013; 62: e7–e13.
  • Lawn SD, Myer L, Bekker L-G, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS. 2006; 20: 1605–12.
  • Lawn SD, Wilkinson RJ, Lipman MCI, Wood R. Immune reconstitution and “unmasking” of tuberculosis during antiretroviral therapy. Am J Respir Crit Care Med. 2008; 177: 680–5.
  • Lawn SD, Harries AD, Meintjes G, Getahun H, Havlir DV, Wood R. Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2012; 26: 2121–33.
  • Vandenbroucke JP, von Elm E, Altman DG, Cøtzsche PC, Mulrow CD, Pocock SJ, etal. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PloS Med. 2007; 4(10): e297. doi: 10.1371/journal.pmed.0040297.